TISSUGLU®

Our lead product under development, TissuGlu®, is a deep wound adhesive for securing planar flaps of tissue to reduce fluid accumulation in the wound (reducing the need for fluid drains). TissuGlu® is designed to meet surgeons' need for a strong, safe, and easy to use surgical adhesive. Unlike "Superglue" products, TissuGlu® is biocompatible and resorbable, making it safe for internal use. Also, unlike "fibrin sealant" products, it is strong, easy to use, and contains no human or animal derivatives. Studies in the laboratory have demonstrated that the bond created with TissuGlu® is as strong after one hour as a normal wound is after a week of healing.

Recent preclinical data shows that TissuGlu® prevented seroma formation in an abdominoplasty animal model. Other in vivo studies show that TissuGlu® is biodegradable and safe for internal use. Cohera Medical recently received a Phase II SBIR grant of $1.5 million to fund ongoing development of TissuGlu®. This grant will aid the company in completing IDE-enabling studies by the end of 2008 and to begin clinical trials in abdominoplasty in Europe soon after.